IONS Q1 2024 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$13B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$119M-8.4% YoY

Gross Profit

$117M98.2% margin

Operating Income

-$150M-125.1% margin

Net Income

-$143M-119.5% margin

EPS (Diluted)

$-0.98

QoQ Revenue Growth

-63.2%

Cash Flow

Operating Cash Flow

-$150M

Free Cash Flow

-$156M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$2.5B

Stockholders' Equity

$297M

Cash & Equivalents

$349M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$119M	$131M	-8.4%
Gross Profit	$117M	$129M	-9.2%
Operating Income	-$150M	-$114M	-31.0%
Net Income	-$143M	-$124M	-14.9%